This session is aimed at providing an overview of the Endocannabinoid System (ECS) and its key concepts of nutritional support. It will then introduce and explain how PEA (Palmitoylethanolamide), a non-cannabis approach will impact the ECS with details in its mechanisms of action and clinical study results in pain and depression.
We know that the brain and the gut are intricately interrelated – indeed the gut is often referred to as our second brain. Exciting new developments in the arena of the gut-brain axis (GBA) – also referred to as the ‘psychobiome’ offers promise for many mental health disorders.
